Illicit drugs and cardiac arrhythmias in athletes
Abstract
The current management of athletes with cardiac arrhythmias has become complicated by the widespread use of illicit drugs, which can be arrhythmogenic. The World Anti-Doping Agency annually updates a list of prohibited substances and methods banned by the International Olympic Committee that includes different classes of substances namely, anabolic androgenic steroids, hormones and related substances, beta2-agonists, diuretics, stimulants, narcotics, cannabinoids, glucocorticosteroids, alcohol, beta-blockers and others. Almost all illicit drugs may cause, through a direct or indirect arrhythmogenic effect, a wide range of cardiac arrhythmias (focal or reentry type, supraventricular and/or ventricular) that can even be lethal and which are frequently sport activity related. A large use of illicit drugs has been documented in competitive athletes, but the arrhythmogenic effect of specific substances is not precisely known. Precipitation of cardiac arrhythmias, particularly in the presence of a latent electrophysiologic substrate including some inherited cardiomyopathies, at risk of sudden death or due to long-term consumption of the substances, should raise the suspicion that illicit drugs may be a possible cause and lead cardiologists to investigate carefully this relationship and appropriately prevent the clinical consequences.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Stimulants such as caffeine and nicotine, or the use of illicit drugs (cocaine, heroin, amphetamines, LSD, synthetic drugs, cannabis, etc.) can lead to sympathetic hyperactivation and sinus tachycardia, even in young subjects without heart disease.
“Likewise, stimulants such as caffeine and nicotine, or the use of illicit drugs (cocaine, heroin, amphetamines, LSD, synthetic drugs, cannabis, etc.) can lead to sympathetic hyperactivation and sinus tachycardia, even in young subjects without heart disease.41,42”
From Management of patients with palpitations: a position paper from the European Heart Rhythm Association (2011) · cites this paper as [41]
Cites
Sudden Death in Young Athletes
Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022783 · Cited by 1,394 · see citing works
Does sports activity enhance the risk of sudden death in adolescents and young adults?
Corrado, D., Basso, C., Rizzoli, G., Schiavon, M., & Thiene, G. (2003) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.03.002 · Cited by 1,311 · see citing works
Priori, S. G., Napolitano, C., Memmi, M., Colombi, B., Drago, F., Gasparini, M., DeSimone, L., Coltorti, F., Bloise, R., Keegan, R. O., et al. (2002) · Circulation · doi:10.1161/01.cir.0000020013.73106.d8 · Cited by 1,168 · see citing works
Increased mortality associated with growth hormone treatment in critically ill adults
Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G., & Hinds, C. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909093411102 · Cited by 1,023 · see citing works
Haller, C. A., & Benowitz, N. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432502 · Cited by 956 · see citing works
INCREASED MORTALITY ASSOCIATED WITH GROWTH HORMONE TREATMENT IN CRITICALLY ILL ADULTS
Akala, J. U. T., Uokonen, E. S. R., Igel, N., Ebster, R. W., Ielsen, M. I. S. N., Andstra, D. U. F. Z., Undelinckx, G. U. V., & Inds, H. J. H. (1999) · Cited by 889 · see citing works
Effects of Androgenic-Anabolic Steroids in Athletes
Hartgens, F., & Kuipers, H. (2004) · Sports Medicine · doi:10.2165/00007256-200434080-00003 · Cited by 878 · see citing works
Tiso, N. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.3.189 · Cited by 813 · see citing works
Shekelle, P. G., Hardy, M. L., Morton, S. C., Maglione, M., Mojica, W. A., Suttorp, M. J., Rhodes, S. L., Jungvig, L., & Gagné, J. (2003) · JAMA · doi:10.1001/jama.289.12.1537 · Cited by 511 · see citing works
Postma, A. V., Denjoy, I., Hoorntje, T. M., Lupoglazoff, J., Costa, A. D., Sébillon, P., Mannens, M. M. A. M., Wilde, A. A. M., & Guicheney, P. (2002) · Circulation Research · doi:10.1161/01.res.0000038886.18992.6b · Cited by 409 · see citing works
Sudden cardiac death in young people with apparently normal heart
Corrado, D. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00254-1 · Cited by 378 · see citing works
The cardiac toxicity of anabolic steroids
Sullivan, M. L., Martinez, C., Gennis, P., & Gallagher, E. J. (1998) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(98)80019-4 · Cited by 337 · see citing works
ADHD Drugs and Cardiovascular Risk
Nissen, S. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068049 · Cited by 331 · see citing works
Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?
Urhausen, A. J. P., Albers, T., & Kindermann, W. (2004) · Heart · doi:10.1136/hrt.2003.015719 · Cited by 275 · see citing works
Cardiovascular Function in Acromegaly
Clayton, R. N. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0009 · Cited by 223 · see citing works
Increased Premature Mortality of Competitive Powerlifters Suspected to Have Used Anabolic Agents
Pärssinen, M., Kujala, U. M., Vartiainen, E. A., Sarna, S. J., & Seppälä, T. T. (2000) · International Journal of Sports Medicine · doi:10.1055/s-2000-304 · Cited by 198 · see citing works
Maron, B. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431911 · Cited by 191 · see citing works
Cardiovascular effects of androgenic-anabolic steroids
Melchert, R. B., & Welder, A. A. (1995) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199509000-00004 · Cited by 187 · see citing works
Cocaine-induced myocardial infarction: An analysis and review of the literature
Hollander, J. E., & Hoffman, R. S. (1992) · Journal of Emergency Medicine · doi:10.1016/0736-4679(92)90212-c · Cited by 183 · see citing works
Ergogenic Aids: A Review of Basic Science, Performance, Side Effects, and Status in Sports
Tokish, J. M., Kocher, M. S., & Hawkins, R. J. (2004) · The American Journal of Sports Medicine · doi:10.1177/0363546504268041 · Cited by 181 · see citing works
Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters
Nieminen, M. S., Ramo, M. P., Viitasalo, M. T., Heikkila, P., Karjalainen, J., Mäntysaari, M., & Heikkilä, J. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014724 · Cited by 177 · see citing works
Human growth hormone doping in sport
Saugy, M., Robinson, N., Saudan, C. M., et al. (2006) · British Journal of Sports Medicine · doi:10.1136/bjsm.2006.027573 · Cited by 175 · see citing works
New aspects of the hormone and cytokine response to training
Steinacker, J., Lormes, W., Reissnecker, S., & Liu, Y.-F. (2004) · European Journal of Applied Physiology · doi:10.1007/s00421-003-0960-x · Cited by 173 · see citing works
Cause and Manner of Death Among Users of Anabolic Androgenic Steroids
Thiblin, I., Lindquist, O., & Rajs, J. (2000) · Journal of Forensic Sciences · doi:10.1520/jfs14635j · Cited by 156 · see citing works
Behavioural Manifestations of Anabolic Steroid Use
Trenton, A., & Currier, G. W. (2005) · CNS Drugs · doi:10.2165/00023210-200519070-00002 · Cited by 156 · see citing works
Left ventricular hypertrophy associated with chronic cocaine abuse.
Brickner, M. E., Willard, J. E., Eichhorn, E. J., Black, J., & Grayburn, P. A. (1991) · Circulation · doi:10.1161/01.cir.84.3.1130 · Cited by 154 · see citing works
Kutscher, E. C., Lund, B. C., & Perry, P. J. (2002) · Sports Medicine · doi:10.2165/00007256-200232050-00001 · Cited by 151 · see citing works
Anabolic Steroid Abuse and Cardiac Sudden Death
Fineschi, V., Baroldi, G., Monciotti, F., Reattelli, L. P., & Turillazzi, E. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-0253-asaacs · Cited by 145 · see citing works
Doping among adolescent athletes
Yesalis, C. E., & Bahrke, M. S. (2000) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2000.0051 · Cited by 141 · see citing works
The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden
Nilsson, S. (2001) · European Journal of Public Health · doi:10.1093/eurpub/11.2.195 · Cited by 133 · see citing works
The Changing Face of Teenage Drug Abuse — The Trend toward Prescription Drugs
Friedman, R. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068010 · Cited by 133 · see citing works
Cardiovascular complications induced by cannabis smoking: a case report and review of the literature
Fisher, B. A. C., Ghuran, A., Vadamalai, V., & Antonios, T. F. (2005) · Emergency Medicine Journal · doi:10.1136/emj.2004.014969 · Cited by 131 · see citing works
Nutritional supplements and doping
Pipe, A., & Ayotte, C. (2002) · Clinical Journal of Sport Medicine · doi:10.1097/00042752-200207000-00008 · Cited by 128 · see citing works
Lenders, J. W. M., Demacker, P. N. M., Vos, J., Jansen, P. L. M., Hoitsma, A. J., Laar, A. V. '., & Thien, T. A. (1988) · International Journal of Sports Medicine · doi:10.1055/s-2007-1024972 · Cited by 126 · see citing works
Analysis of Over-the-Counter Dietary Supplements
Green, G. A., Catlin, D. H., & Starcevic, B. (2001) · Clinical Journal of Sport Medicine · doi:10.1097/00042752-200110000-00008 · Cited by 126 · see citing works
Cardiovascular Toxicities of Performance-Enhancing Substances in Sports
Dhar, R., Stout, C. W., Link, M. S., Homoud, M. K., Weinstock, J., & Estes, N. A. M. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.10.1307 · Cited by 122 · see citing works
Cardiac effects of anabolic steroids
Payne, J. R., Kotwinski, P. J., & Montgomery, H. (2004) · Heart · doi:10.1136/hrt.2003.025783 · Cited by 119 · see citing works
Deligiannis, A. P., Björnstad, H. H., Carré, F., Heidbüchel, H., Kouidi, E. J., Panhuyzen-Goedkoop, N. M., Pigozzi, F., Schänzer, W., Vanhees, L., & on behalf of the ESC Study Group of Sports Cardiology (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000224482.95597.7a · Cited by 117 · see citing works
Karila, T. A., Karjalainen, J., Mäntysaari, M., Viitasalo, M. T., & Seppälä, T. A. (2003) · International Journal of Sports Medicine · doi:10.1055/s-2003-40702 · Cited by 111 · see citing works
Cannabis as a precipitant of cardiovascular emergencies
Lindsay, A. C., Foale, R. A., Warren, O. J., et al. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.10.038 · Cited by 109 · see citing works
Brugada-Type Electrocardiographic Pattern Induced by Cocaine
Littmann, L., Monroe, M. H., & Svenson, R. H. (2000) · Mayo Clinic Proceedings · doi:10.4065/75.8.845 · Cited by 107 · see citing works
Cocaine Cardiovascular Toxicity
Karch, S. B. (2005) · Southern Medical Journal · doi:10.1097/01.smj.0000168701.08879.3f · Cited by 103 · see citing works
McBride, B. F., Karapanos, A. K., Krudysz, A., Kluger, J., Coleman, C. I., & White, C. M. (2004) · JAMA · doi:10.1001/jama.291.2.216 · Cited by 102 · see citing works
Anabolic steroid-induced tendon pathology
Laseter, J. T., & Russell, J. A. (1991) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199101000-00001 · Cited by 98 · see citing works
Bauman, J. L., Grawe, J. J., Winecoff, A. P., et al. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb04003.x · Cited by 97 · see citing works
Atrial fibrillation and anabolic steroids
Sullivan, M. L., Martinez, C., & Gallagher, E. J. (1999) · Journal of Emergency Medicine · doi:10.1016/s0736-4679(99)00095-5 · Cited by 97 · see citing works
Cocaine, Alcohol Mix in Body to Form Even Longer Lasting, More Lethal Drug
Randall, T. (1992) · JAMA · doi:10.1001/jama.1992.03480080013002 · Cited by 96 · see citing works
Report of the NASPE Policy Conference on Arrhythmias and the Athlete
ESTES, N. A. M., LINK, M. S., CANNOM, D., NACCARELLI, G. V., PRYSTOWSKY, E. N., MARON, B. J., & OLSHANSKY, B. (2001) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2001.01208.x · Cited by 95 · see citing works
Karila, T. A., Hovatta, O., & Seppälä, T. (2004) · International Journal of Sports Medicine · doi:10.1055/s-2004-819936 · Cited by 86 · see citing works
Cardiovascular toxicity after ingestion of “herbal ecstacy”
Zahn, K. A., Li, R. L., & Purssell, R. A. (1999) · Journal of Emergency Medicine · doi:10.1016/s0736-4679(98)00194-2 · Cited by 82 · see citing works
Acute Electrophysiologic Effects of Inhaled Salbutamol in Humans
Kallergis, E. M., Manios, E. G., KANOUPAKIS, E. M., et al. (2005) · CHEST Journal · doi:10.1378/chest.127.6.2057 · Cited by 76 · see citing works
Cocaine: A Review of Its Toxic Actions on Cardiac Function
Billman, G. E. (1995) · Critical Reviews in Toxicology · doi:10.3109/10408449509021610 · Cited by 74 · see citing works
Cannabis use to enhance sportive and non-sportive performances among French sport students
Lorente, F. O., Peretti‐Watel, P., & Grélot, L. (2005) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.01.019 · Cited by 71 · see citing works
Stolt, A., Karila, T. A., Viitasalo, M. T., Mäntysaari, M., Kujala, U. M., & Karjalainen, J. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00299-4 · Cited by 70 · see citing works
Myocardial infarction due to amphetamine.
Carson, P., Oldroyd, K., & Phadke, K. (1987) · BMJ · doi:10.1136/bmj.294.6586.1525 · Cited by 69 · see citing works
Use of Recombinant Human Erythropoietin as an Antianemic and Performance Enhancing Drug
Jelkmann, W. (2000) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201003379068 · Cited by 69 · see citing works
Tainted Glory — Doping and Athletic Performance
Noakes, T. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048208 · Cited by 68 · see citing works
Campos, D. R., Yonamine, M., & Moreau, R. L. D. M. (2003) · Sports Medicine · doi:10.2165/00007256-200333060-00001 · Cited by 65 · see citing works
Myocardial disarray: an architectural disorganization linked with adrenergic stress?
Fineschi, V., Silver, M. D., Karch, S. B., et al. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.01.022 · Cited by 64 · see citing works
Anabolic Steroid Use as the Possible Precipitant of Dilated Cardiomyopathy
Ferrera, P. C., Putnam, D., & Verdile, V. P. (2008) · Cardiology · doi:10.1159/000177333 · Cited by 62 · see citing works
Prolonged QT interval and cocaine use
Perera, R., Kraebber, A., & Schwartz, M. J. (1997) · Journal of Electrocardiology · doi:10.1016/s0022-0736(97)80047-7 · Cited by 61 · see citing works
Effect of Acute Cocaine Administration on the QTc Interval of Habitual Users
Magnano, A. R., Talathoti, N. B., HALLUR, R., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.046 · Cited by 57 · see citing works
Impairment of IGF-I gene splicing and MGF expression associated with muscle wasting
Goldspink, G. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.006 · Cited by 56 · see citing works
Ventricular thrombosis and systemic embolism in bodybuilders: etiology and management
McCarthy, K., Tang, A. T. M., Dalrymple-Hay, M. J. R., et al. (2000) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(00)01572-1 · Cited by 56 · see citing works
Supplements and drugs used to enhance athletic performance
Congeni, J. A., & Miller, S. D. (2002) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(01)00013-x · Cited by 56 · see citing works
Carlsen, K. ‐., Hem, E., Stensrud, T., et al. (2001) · Respiratory Medicine · doi:10.1053/rmed.2001.1105 · Cited by 52 · see citing works
Ephedra–Associated Cardiomyopathy
Naik, S., & Freudenberger, R. S. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d408 · Cited by 50 · see citing works
Shulman, D. I., Root, A. W., Diamond, F., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030030 · Cited by 49 · see citing works
Molecular Determinants of Cocaine Block of Human Ether-á-go-go-Related Gene Potassium Channels
Guo, J., Gang, H., & Zhang, S. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098103 · Cited by 48 · see citing works
Ehrnborg, C., Bengtsson, B., & Rosén, T. (2000) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2000.0054 · Cited by 47 · see citing works
Impairment of IGF-I gene splicing and MGF expression associated with muscle wasting
Goldspink, G. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.10.001 · Cited by 46 · see citing works
Testosterone, Sex Hormone-Binding Globulin, Lipoproteins, and Vascular Disease Risk
Dickerman, R. D., McConathy, W. J., & Zachariah, N. Y. (1997) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679700400508 · Cited by 45 · see citing works
Electrocardiographic abnormalities after acute administration of cocaine in the rat
Hale, S. L., Lehmann, M. H., & Kloner, R. A. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90024-6 · Cited by 42 · see citing works
Palo, E. F. D., Gatti, R. D., Lancerin, F., Cappellin, E., & Spinella, P. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00378-3 · Cited by 41 · see citing works
Pirwitz, M. J. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430110100011 · Cited by 41 · see citing works
Informed Decision-Making on Sympathomimetic Use in Sport and Health
Bouchard, R. A., Weber, A. R., & Geiger, J. D. (2002) · Clinical Journal of Sport Medicine · doi:10.1097/00042752-200207000-00003 · Cited by 40 · see citing works
Clark, B. M., & Schofield, R. S. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.5.756.63592 · Cited by 39 · see citing works
Su, J., Li, J., Li, W., et al. (2004) · International Journal of Toxicology · doi:10.1080/10915810490471361 · Cited by 38 · see citing works
Detection of DNA-Recombinant Human Epoetin-Alfa as a Pharmacological Ergogenic Aid
Wilber, R. L. (2002) · Sports Medicine · doi:10.2165/00007256-200232020-00004 · Cited by 36 · see citing works
Parker, R. B., Perry, G. Y., Horan, L. G., & Flowers, N. C. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199912000-00014 · Cited by 35 · see citing works
Controversies Regarding the Effects of Growth Hormone on the Heart
Meyers, D. E., & Cuneo, R. C. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1521 · Cited by 33 · see citing works
Does Exogenous Growth Hormone Improve Athletic Performance?
Dean, H. (2002) · Clinical Journal of Sport Medicine · doi:10.1097/00042752-200207000-00009 · Cited by 33 · see citing works
Arrhythmogenic effects of illicit drugs in athletes.
Furlanello, F., Bentivegna, S., Cappato, R., et al. (2003) · PubMed · Cited by 31 · see citing works
Self-citation(2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.004 · Cited by 29 · see citing works
Cocaine Induces Apoptosis in Human Coronary Artery Endothelial Cells
He, J., Xiao, Y., & Zhang, L. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200004000-00010 · Cited by 28 · see citing works
Cocaine induced prolongation of the QT interval: Figure 1
Taylor, D. M., Parish, D., Thompson, L., & Cavaliere, M. (2004) · Emergency Medicine Journal · doi:10.1136/emj.2002.003251 · Cited by 27 · see citing works
Risk of Arrhythmia and Sudden Death
Lip, G. Y. H. (2002) · Journal of the Royal Society of Medicine · doi:10.1177/014107680209500219 · Cited by 23 · see citing works
The Adverse Effects of Elite Competition on Health and Well-Being
Pipe, A. (2001) · Canadian Journal of Applied Physiology · doi:10.1139/h2001-054 · Cited by 23 · see citing works
Sudden Cardiac Death in the Athlete
Bodenheimer, M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-1-199901050-00040 · Cited by 20 · see citing works
Hypertrophic Cardiomyopathy -Sports-Related Aspects of Diagnosis, Therapy, and Sports Eligibility
Hipp, A., Heitkamp, H., Röecker, K., & Dickhuth, H.-H. (2004) · International Journal of Sports Medicine · doi:10.1055/s-2003-45227 · Cited by 18 · see citing works
[Dilated cardiomyopathy in a user of anabolic steroids].
Schollert, P. V., & Bendixen, P. M. (1993) · PubMed · Cited by 18 · see citing works
Turhan, H., Aksoy, Y., Tekin, G., & Yetkın, E. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.11.020 · Cited by 16 · see citing works
Rosén, T. (2006) · Hormone Research in Paediatrics · doi:10.1159/000096631 · Cited by 8 · see citing works
Competitive Athletes with Arrhythmias: Classification, Evaluation and Treatment
Furlanello, F., Bertoldi, A., Fernando, F., & Biffi, A. (2000) · Developments in cardiovascular medicine · doi:10.1007/978-94-017-0789-3_7 · Cited by 7 · see citing works
Self-citationSpontaneous atrial fibrillation in a freestyle skier
Whyte, G. P., Stephens, N. G., Sharma, S., et al. (2004) · British Journal of Sports Medicine · doi:10.1136/bjsm.2003.006197 · Cited by 7 · see citing works
Pathology of Sudden Death in Young Athletes: The European Experience
Thiene, G., Basso, C., & Corrado, D. (2000) · Developments in cardiovascular medicine · doi:10.1007/978-94-017-0789-3_5 · Cited by 6 · see citing works
Pirnay, F. (2001) · PubMed · Cited by 4 · see citing works
Gauthier, J. B. (2006) · PubMed · Cited by 4 · see citing works
Hipp, A., Heitkamp, H., Röecker, K., et al. (2004) · International Journal of Sports Medicine · doi:10.1055/s-2004-821319 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Raviele, A., Giada, F., Bergfeldt, L., Blanc, J. J., Blomstrom-Lundqvist, C., Mont, L., Morgan, J. M., Raatikainen, M. J. P., Steinbeck, G., Viskin, S., et al. (2011) · Europace · doi:10.1093/europace/eur130 · Cited by 149 · see citing works
- Authors
- Furlanello, F., Serdoz, L. V., Cappato, R., & De Ambroggi, L.
- Affiliations
- University of Milan (IT)
- Arrhythmias and Electrophysiology Center, Department of Cardiology, IRCCS Policlinico San Donato, University of Milan, Italy
- Corresponding author
- Furlanello, Francesco
- Venue
- European Journal of Cardiovascular Prevention & Rehabilitation
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-08
- Volume
- 14
- Issue
- 4
- Pages
- 487-494
- ISSN
- 1741-8267 (ISSN-L)
- OpenAlex
- W2096238532
- Cited by
- 70
- References
- 99
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 3 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 4 · 2017: 2 · 2016: 4 · 2015: 3 · 2014: 7 · 2013: 6 · 2012: 5
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Cardiovascular Prevention & Rehabilitation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
- Social Sciences › Sociology and Political Science › Doping in Sports
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- illicit drugs, cardiac arrhythmias, athletes, doping, prohibited substances, anabolic steroids, beta2-adrenergic agonists, diuretics, stimulants, cannabinoids, beta-blockers, sudden cardiac death, familial cardiomyopathy, supraventricular arrhythmias, ventricular arrhythmias
- MeSH terms
- Arrhythmias, Cardiac, Doping in Sports, Humans, Sports, Illicit Drugs, Substance Abuse Detection, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review